JANEL CORP SEC 10-Q Report

Janel Corp, a diversified logistics and life sciences company, has released its Form 10-Q report for the quarter ended June 30, 2025. The report highlights significant growth in both financial and operational metrics, driven by increased demand, strategic acquisitions, and operational efficiencies.

Financial Highlights

Total Revenues: Janel Corp reported total revenues of $49.145 million for the three months ended June 30, 2025, marking a 5.2% increase from the prior year period. For the nine months ended June 30, 2025, total revenues were $151.230 million, up 16.4% from the previous year, primarily due to growth in the Logistics and Life Sciences segments.

Gross Profit: The company achieved a gross profit of $16.110 million for the three months ended June 30, 2025, an increase of 6.8% from the prior year period. For the nine months ended June 30, 2025, gross profit was $47.823 million, up 11.1% from the previous year, benefiting from improvements in product mix and price increases in the Life Sciences segment.

Income from Operations: Income from operations for the three months ended June 30, 2025, was $1.931 million, a significant 63.9% increase from the prior year period. For the nine months ended June 30, 2025, income from operations was $5.310 million, reflecting a 92.5% increase, driven by higher freight rates and improved operational efficiency.

Net Income: Janel Corp reported a net income of $0.887 million for the three months ended June 30, 2025, compared to a net loss of $(0.191) million in the prior year period. For the nine months ended June 30, 2025, net income was $2.986 million, a substantial increase from $0.304 million in the previous year, largely due to stronger revenues in the Logistics segment.

Net Income (Loss) Available to Common Stockholders: The net income available to common stockholders was $0.810 million for the three months ended June 30, 2025, compared to a net loss of $(0.276) million in the prior year period. For the nine months ended June 30, 2025, this figure was $2.472 million, up from $0.062 million in the previous year.

Diluted EPS: The diluted earnings per share (EPS) for the three months ended June 30, 2025, was $0.74, compared to $(0.16) in the prior year period. For the nine months ended June 30, 2025, diluted EPS was $2.48, up from $0.25 in the previous year.

Business Highlights

Logistics Segment Performance: The Logistics segment experienced a 6.3% increase in revenues for the three months ended June 30, 2025, driven by higher freight rates, the inclusion of acquired revenue from the Airschott acquisition, and increased demand as customers prepared for anticipated tariff increases. The gross profit margin improved to 27.7% from 26.9% in the prior year period.

Life Sciences Segment Performance: The Life Sciences segment saw an 8.8% increase in revenues for the three months ended June 30, 2025, driven by increased diagnostic and research reagent sales. The gross profit margin improved to 82.1% from 81.0% due to product mix improvements and price increases.

Manufacturing Segment Performance: The Manufacturing segment reported a 14.6% decrease in revenues for the three months ended June 30, 2025, attributed to the timing of larger orders compared to the prior year period. The gross profit margin slightly decreased to 52.5% from 54.2%.

New Acquisitions: Janel Corp completed the acquisition of 80% of Biosensis on June 4, 2025, enhancing its Life Sciences segment. This acquisition is expected to expand product offerings and contribute to future growth.

Operational Efficiency: Despite the acquisition of Airschott, selling, general, and administrative expenses in the Logistics segment remained stable for the three months ended June 30, 2025, reflecting operational efficiency.

Future Outlook: Janel Corp plans to continue its growth strategy through organic growth and acquisitions, focusing on reasonably priced companies with strong management teams and stable earnings. The company aims to expand its portfolio into new strategic segments.

SEC Filing: JANEL CORP [ JANL ] - 10-Q - Aug. 01, 2025